1Goettler CE,Stellato TA. Initial presentation of Crohn's disease in pregnancy: report of a ease [ J ]. Dis the Colon Rectum, 2003,46 : 4O6 -410.
2Komfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease - a population-based cohort study[ J ]. Am J Obstet Gynecol, 1997,177:942 -946.
3Hanan I. Inflammatory bowel disease in the pregnant woman [ J ]. Compr Ther, 1993,19:91 -95.
4Abramson D, Jankelson IR, Milner LR. Pregnancy and colitis [ J ]. Am J Obstet Gynecol, 1951,61 : 121 - 129.
5Cappell MS,Colon VJ,Sidhom OA. A study of 10 medical centres of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups [ J ]. Dig Dis Sci, 1996,41 : 2353 -2361.
6Katz JA, Pore G. Inflammatory bowel disease and pregnancy [ J ]. Inflamm Bowel Dis,2001,7:146 -157.
7Jarnerot G, Into-Malberg MB, Esbjtorner E. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites[ J]. Stand J Gastroenterol, 1981,16:693 - 697.
9Mogadam M,Dobbins WO,Korelitz Bl,et al. Pregnancy in inflammatory bowel disease:effect of sulfasalazine and corticosteroids on fetal outcome [ J ]. Gastroenterology, 1981,80:72 - 76.
10Hanauer SB, Rob IM, Pruitt R, et al. Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis : a doseranging study. U. S. Budesonide Enema Study Group[ J]. Gastroenterology, 1998,115:525.
4Habal FM, Huang VW. Review article: a decision-making algorithm for the management of pregnancy in the inflam- matory bowel disease patient [ J ]. Aliment Pharmacol T- her,2012,35 (5) :501-515.
5Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease : Special situations [ J ]. J Crohns Colitis,2010,4( 1 ) :63-101.
6Beaulieu DB, Kane S. Inflammatory bowel disease in preg- nancy [ J]. World J Gastroenterol, 2011,17 (22) : 2696- 2701.
7Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease : Current management [ J ]. J Crohns Colitis,2010,4( 1 ) :28-62.
8Ford AC, Kane SV, Khan KJ, et al. Efficacy of 5-aminosa- lieylates in Crohn's disease:systematic review and meta-a- nalysis [ J ]. Am J Gastroentero1,2011,106 : 617-629.
9Mahadevan U, Corley DA. Aminosalieylate ( ASA ) use during pregnancy is not associated with increased adverse events or congenital malformations ( CM ) in women with inflammatory bowel disease(IBD) [J]. Gastroenterology, 2006,130 ( Supp12 ) : A40.
10Steinhart AH, Ewe K, Griffiths AM, et al. Corticosteroids for maintenance of remission in Crohn's disease [ J ]. Co- chrane Database Syst Rev,2003, (4) :CD000301.
